Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
Related stories
Box taps Nvidia’s Nemotron for new agent-first content retrieval system
RadianX promises solar-powered devices that never need charging
Motorola's new Signature 27 has it all if you can stomach the $1,600 price tag
Motorola Signature 27: Specs, Price, Features, Release Date
A YC startup is putting $1M behind five unsolved materials science problems for AI
Agility Robotics' Nasdaq debut invites scrutiny of humanoid robot market